Skip to main content

ITP An Update: New Routes, New Options and New Outcomes

Course Experts: Shahrier Hossain, PharmD

Course Description: This course compares different treatment options for chronic thrombocytopenia, recommends a thrombopoietin agonist based on patient-specific factors, and identifies the role of fostamatinib in therapy.

Credits: CEUs will be granted for pharmacists in disease state management/drug therapy.

Immune Thrombocytopenia (ITP), Thrombocytopenia, Fostamatinib, Splenectomy, Rituximab, TPO Receptor Agonists (TPO-RAs), Romiplostim, Eltrombopag, Avatrombopag, Pathophysiology, Autoantibodies, Megakaryocytes, Reticuloendothelial System, Hepatotoxicity, Cataract Formation, Bone Marrow Fibrosis, MDS Transformation, IVIG, Anti-D, Steroid Refractory